Quetiapine: Research, Dosing, and Where to Buy in 2026
A research-first profile for Quetiapine (Seroquel), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Quetiapine is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, 3 attributed expert mentions, and 1 transcript dosing protocol for Quetiapine, each linked to its source.
- Also indexed as Seroquel.
- 1 aggregated dosing-protocol mention from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
- Evidence level in this entry is marked as fda_approved.
What is Quetiapine?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
How does Quetiapine work?
Experts on mechanism · 1 cited mention
"there are drugs called atypical antipsychotics these drugs in general block dopamine receptors d1 and d2 receptors sometimes they also block at serotonin receptors so these drugs like most famously seroquel how haloperidol"
What is Quetiapine researched for?
Atypical antipsychotic that blocks D1/D2 dopamine receptors; at low dose acts as a powerful hypnotic and may help up-regulate dopamine receptors during addiction recovery.
Experts on uses and effects · 1 cited mention
"if you were to take that especially while recovering from addiction it will reduce your mania it will stabilize your mood and it will likely reduce the effect that dopamine is having at those receptors causing it to up regulate it faster in your recovery period"
Quetiapine Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Leo and Longevity | Repairing the Dopamine System: 9-me-BC | 00:12:19 | Host reported (source FGFCPvTA99k) using a low dose of 50 mg quetiapine before bed during addiction recovery, describing it as helping reduce mania, stabilize mood, and support dopamine receptor up-regulation. Host characterized this as an advanced approach requiring psychiatrist supervision. Anecdotal account only - quetiapine is a prescription medication and not a peptide; this is not medical advice. | anecdotal |
Where to Buy Quetiapine in 2026
No tracked vendor recommendations for Quetiapine yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
What Experts Say
0 experts across our source library discuss Quetiapine. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.
-
“if you were to take that especially while recovering from addiction it will reduce your mania it will stabilize your mood and it will likely reduce the effect that dopamine is having at those...”
See 2 more expert mentions →
-
“if someone wants to take a low dose for example cervical which does cause insulin sensitivity issues but if you were to take a low dose like 50 milligrams before bed which by the way it's a very...”
-
“there are drugs called atypical antipsychotics these drugs in general block dopamine receptors d1 and d2 receptors sometimes they also block at serotonin receptors so these drugs like most...”
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Quetiapine. Each line links to the original source.
- "For homogeneous dichotomous data the Peto odds ratio (OR), 95% confidence interval (CI) and, where appropriate, the number needed to treat (NNT) was calculated on an intention-to-treat basis." · Srisurapanont M et al, 2000 PubMed
- "Apart from that of 'leaving the study early', all other results may be prone to bias and should be viewed with caution since dropout rates are high (48-61%) in each arm of all studies." · Srisurapanont M et al, 2000 PubMed
- "There are data suggesting less people allocated quetiapine leave the study early (53%) than those in the placebo group (61%) (OR 0.67 CI 0.48-0." · Srisurapanont M et al, 2000 PubMed
- "High proportions of trial participants also leave when quetiapine is compared to chlorpromazine or haloperidol (57% by six weeks)." · Srisurapanont M et al, 2000 PubMed
Research and Studies
8 PubMed-indexed papers reference Quetiapine. Top 8 shown.
Legal Status
Quetiapine is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Quetiapine FDA-approved?
Quetiapine is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for Quetiapine?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on Quetiapine?
8 PubMed-indexed paper(s) reference Quetiapine in our current research feed. See the Research and Studies section above for citations.